Joel Ackerman
2017 - Champions Oncology
In 2017, Joel Ackerman earned a total compensation of $325K as Former Chief Executive Officer at Champions Oncology, a 3% decrease compared to previous year.
Compensation breakdown
| Option Awards | $325,000 |
|---|---|
| Total | $325,000 |
Ackerman received $325K in option awards, accounting for 100% of the total pay in 2017.
Rankings
In 2017, Joel Ackerman's compensation ranked 13,139th out of 14,666 executives tracked by ExecPay. In other words, Ackerman earned more than 10.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 13,139 out of 14,666 | 10th |
Division Manufacturing | 5,167 out of 5,768 | 10th |
Major group Chemicals And Allied Products | 1,875 out of 2,074 | 10th |
Industry group Drugs | 1,562 out of 1,730 | 10th |
Industry Biological Products, Except Diagnostic Substances | 287 out of 316 | 9th |
Source: SEC filing on August 28, 2017.
Ackerman's colleagues
We found two more compensation records of executives who worked with Joel Ackerman at Champions Oncology in 2017.